Julie L. Gerberding

MRK

Julie L. Gerberding serves as EVP, Chief Patient Officer at Merck & Co., Inc. (MRK). This page tracks their complete SEC Form 4 insider trading history including stock purchases and sales.

Total Buys

0 trades

$0.00

Total Sells

1 trades

$8.46M

Net Position

Net Seller

$8.46M

Companies Traded

MRK

Active Period

Nov 2021

1 total trades

Most Recent

Sell MRK

Nov 3, 2021 · $8.46M

Julie L. Gerberding's Insider Trading at Merck & Co., Inc. (MRK)

Buys

0 · $0.00

Sells

1 · $8.46M

Total Shares Bought

Total Shares Sold

96,270

MRK Price Chart

Loading chart...

Date	Type	Shares	Avg Price	Value	Shares After
Nov 3, 2021	Sell	96,270	$87.91	$8.46M	39,162

Related Insiders

Chirfi Guindo

officer: Chief Marketing Officer

MRKSell · Feb 12, 2026

Dean Y Li

officer: Executive VP & President, MRL

MRKSell · Feb 10, 2026

Jennifer Zachary

officer: EVP, General Counsel

MRKSell · Feb 9, 2026

Johannes Jacobus Oosthuizen

officer: President, U.S. Market

MRKSell · Feb 6, 2026

Dalton E. Smart III

SVP Fin. - Global Controller

MRKSell · Feb 6, 2026

David Michael Williams

officer: EVP,Chief Info&Digital Officer

MRKSell · Feb 6, 2026

Caroline Litchfield

officer: EVP & CFO

MRKSell · Feb 6, 2026

Richard R. DeLuca

officer: EVP&Pres, Merck Animal Heallth

MRKSell · Feb 6, 2026

Explore More Insider Trading Data

MRK Insider Trading Activity

View all insider trades at Merck & Co., Inc.

Healthcare Sector Insider Trades

See insider activity across healthcare stocks

Latest Insider Buys

Most recent insider purchases across all stocks

CEO Stock Purchases

Track CEO buying activity